UBE2Q1
Ubiquitin-conjugating enzyme E2 Q1
Also known as: NICE-5, PRO3094, UB2Q1_HUMAN, UBE2Q
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z7E8
- Gene
- UBE2Q1
- Ensembl
- ENSG00000160714
- Chromosome
- 1
- Canonical length
- 422 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is 98% identical to the mouse counterpart. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>Q7Z7E8|UBE2Q1
1 MQQPQPQGQQ QPGPGQQLGG QGAAPGAGGG PGGGPGPGPC LRRELKLLES IFHRGHERFR
61 IASACLDELS CEFLLAGAGG AGAGAAPGPH LPPRGSVPGD PVRIHCNITE SYPAVPPIWS
121 VESDDPNLAA VLERLVDIKK GNTLLLQHLK RIISDLCKLY NLPQHPDVEM LDQPLPAEQC
181 TQEDVSSEDE DEEMPEDTED LDHYEMKEEE PAEGKKSEDD GIGKENLAIL EKIKKNQRQD
241 YLNGAVSGSV QATDRLMKEL RDIYRSQSFK GGNYAVELVN DSLYDWNVKL LKVDQDSALH
301 NDLQILKEKE GADFILLNFS FKDNFPFDPP FVRVVSPVLS GGYVLGGGAI CMELLTKQGW
361 SSAYSIESVI MQISATLVKG KARVQFGANK SQYSLTRAQQ SYKSLVQIHE KNGWYTPPKE
421 DGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2Q1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 34 nTPM
- testis: 33 nTPM
- tonsil: 33 nTPM
- spleen: 31 nTPM
- bone marrow: 30 nTPM
- pancreas: 30 nTPM
Single-cell type
- megakaryocytes: 99 nCPM
- platelets: 86 nCPM
- kupffer cells: 83 nCPM
- esophageal apical cells: 75 nCPM
- neutrophils: 71 nCPM
- breast myoepithelial cells: 54 nCPM
Immune cell
- basophil: 3.9 nTPM
- T-reg: 3.2 nTPM
- eosinophil: 2.9 nTPM
- memory CD8 T-cell: 2.7 nTPM
- naive CD8 T-cell: 2.5 nTPM
- plasmacytoid DC: 2.4 nTPM
Brain region
- hypothalamus: 29 nTPM
- cerebral cortex: 28 nTPM
- pons: 28 nTPM
- thalamus: 27 nTPM
- basal ganglia: 26 nTPM
- hippocampal formation: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.35
- DepMap mean gene effect
- -0.32
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 21% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- embryo implantation
- fertilization
- mating behavior
- prolactin secretion
- protein polyubiquitination
- reproductive system development
- suckling behavior
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2Q1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2Q1 as an antibody target. Whether an autoantibody or antibody against UBE2Q1 could matter depends on whether native UBE2Q1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2Q1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2Q1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...